Reduced sulfotransferase SULT2A1 activity in patients with Alzheimer's disease
Language English Country Czech Republic Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
26680489
DOI
10.33549/physiolres.933160
PII: 933160
Knihovny.cz E-resources
- MeSH
- Enzyme Activation physiology MeSH
- Alzheimer Disease blood diagnosis MeSH
- Biomarkers blood MeSH
- Humans MeSH
- Aged MeSH
- Sulfotransferases blood MeSH
- Zona Reticularis metabolism MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- alcohol sulfotransferase MeSH Browser
- Biomarkers MeSH
- Sulfotransferases MeSH
Steroids are important components in the pathophysiology of Alzheimer's disease (AD). Although their role has been studied, the corresponding metabolomic data is limited. In the present study we evaluate the role of steroid sulfotransferase SULT2A1 in the pathophysiology of AD on the basis of circulating steroids (measured by GC-MS), in which the sulfation catalyzed by SULT2A1 dominates over glucuronidation (pregnenolone/sulfate, DHEA/sulfate, androstenediol/sulfate and 5alpha-reduced pregnane and androstane catabolites). To estimate a general trend of SUL2A1 activity in AD patients we compared the ratios of steroid conjugates to their unconjugated counterparts (C/U) in controls (11 men and 22 women) and AD patients (18 men and 16 women) for individual circulating steroids after adjustment for age and BMI using ANCOVA model including the factors AD status and gender. Decreased C/U ratio for the C19 steroids demonstrate an association between attenuated sulfation of C19 steroids in adrenal zona reticularis and the pathophysiology of AD.
References provided by Crossref.org
Steroid Sulfation in Neurodegenerative Diseases
